Conglomerates
Compare Stocks
4 / 10Stock Comparison
RCMT vs TBI vs MAN vs KELYA
Revenue, margins, valuation, and 5-year total return — side by side.
Staffing & Employment Services
Staffing & Employment Services
Staffing & Employment Services
RCMT vs TBI vs MAN vs KELYA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Conglomerates | Staffing & Employment Services | Staffing & Employment Services | Staffing & Employment Services |
| Market Cap | $204M | $170M | $1.38B | $355M |
| Revenue (TTM) | $319M | $1.25B | $17.96B | $3.09B |
| Net Income (TTM) | $16M | $-53M | $-13M | $-266M |
| Gross Margin | 27.2% | 28.4% | 16.7% | 26.3% |
| Operating Margin | 7.9% | -2.6% | 0.8% | -2.8% |
| Forward P/E | 12.4x | — | 8.1x | 11.2x |
| Total Debt | $26M | $171M | $2.39B | $159M |
| Cash & Equiv. | $3M | $25M | $871M | $33M |
RCMT vs TBI vs MAN vs KELYA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| RCM Technologies, I… (RCMT) | 100 | 2150.7 | +2050.7% |
| TrueBlue, Inc. (TBI) | 100 | 36.3 | -63.7% |
| ManpowerGroup Inc. (MAN) | 100 | 43.2 | -56.8% |
| Kelly Services, Inc. (KELYA) | 100 | 65.8 | -34.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RCMT vs TBI vs MAN vs KELYA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RCMT carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 14.7%, EPS growth 28.0%, 3Y rev CAGR 3.9%
- 471.3% 10Y total return vs MAN's -31.5%
- 14.7% revenue growth vs KELYA's -1.9%
- 5.1% margin vs KELYA's -8.6%
TBI plays a supporting role in this comparison — it may shine differently against other peers.
MAN is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 0 yrs, beta 0.89, yield 4.8%
- Beta 0.89, yield 4.8%, current ratio 1.11x
- Better valuation composite
- Beta 0.89 vs RCMT's 1.18
KELYA is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.96, Low D/E 16.3%, current ratio 1.54x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 14.7% revenue growth vs KELYA's -1.9% | |
| Value | Better valuation composite | |
| Quality / Margins | 5.1% margin vs KELYA's -8.6% | |
| Stability / Safety | Beta 0.89 vs RCMT's 1.18 | |
| Dividends | 4.8% yield, vs KELYA's 3.2%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +38.7% vs MAN's -24.5% | |
| Efficiency (ROA) | 12.5% ROA vs KELYA's -11.3%, ROIC 26.9% vs -4.0% |
RCMT vs TBI vs MAN vs KELYA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
RCMT vs TBI vs MAN vs KELYA — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
RCMT leads in 3 of 6 categories
MAN leads 1 • TBI leads 0 • KELYA leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
RCMT leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MAN is the larger business by revenue, generating $18.0B annually — 56.2x RCMT's $319M. RCMT is the more profitable business, keeping 5.1% of every revenue dollar as net income compared to KELYA's -8.6%. On growth, RCMT holds the edge at +12.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $319M | $1.2B | $18.0B | $3.1B |
| EBITDAEarnings before interest/tax | $27M | -$10M | $236M | -$54M |
| Net IncomeAfter-tax profit | $16M | -$53M | -$13M | -$266M |
| Free Cash FlowCash after capex | $17M | -$60M | -$161M | $66M |
| Gross MarginGross profit ÷ Revenue | +27.2% | +28.4% | +16.7% | +26.3% |
| Operating MarginEBIT ÷ Revenue | +7.9% | -2.6% | +0.8% | -2.8% |
| Net MarginNet income ÷ Revenue | +5.1% | -4.3% | -0.1% | -8.6% |
| FCF MarginFCF ÷ Revenue | +5.4% | -4.8% | -0.9% | +2.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +12.4% | -100.0% | +7.1% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +116.2% | -37.5% | +36.2% | -2.1% |
Valuation Metrics
MAN leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, RCMT's 8.1x EV/EBITDA is more attractive than TBI's 154.1x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $204M | $170M | $1.4B | $355M |
| Enterprise ValueMkt cap + debt − cash | $227M | $316M | $2.9B | $481M |
| Trailing P/EPrice ÷ TTM EPS | 13.40x | -3.48x | -102.90x | -1.36x |
| Forward P/EPrice ÷ next-FY EPS est. | 12.45x | — | 8.12x | 11.15x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 8.06x | 154.12x | 8.94x | — |
| Price / SalesMarket cap ÷ Revenue | 0.64x | 0.11x | 0.08x | 0.08x |
| Price / BookPrice ÷ Book value/share | 4.77x | 0.61x | 0.67x | 0.35x |
| Price / FCFMarket cap ÷ FCF | 11.76x | — | — | 3.11x |
Profitability & Efficiency
RCMT leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
RCMT delivers a 40.9% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-25 for KELYA. KELYA carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to MAN's 1.16x. On the Piotroski fundamental quality scale (0–9), RCMT scores 8/9 vs MAN's 1/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +40.9% | -18.7% | -0.6% | -24.6% |
| ROA (TTM)Return on assets | +12.5% | -8.1% | -0.1% | -11.3% |
| ROICReturn on invested capital | +26.9% | -5.2% | +5.6% | -4.0% |
| ROCEReturn on capital employed | +31.6% | -5.3% | +6.2% | -4.3% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 4 | 1 | 5 |
| Debt / EquityFinancial leverage | 0.56x | 0.62x | 1.16x | 0.16x |
| Net DebtTotal debt minus cash | $23M | $146M | $1.5B | $126M |
| Cash & Equiv.Liquid assets | $3M | $25M | $871M | $33M |
| Total DebtShort + long-term debt | $26M | $171M | $2.4B | $159M |
| Interest CoverageEBIT ÷ Interest expense | 9.05x | -46.19x | 1.98x | -12.07x |
Total Returns (Dividends Reinvested)
RCMT leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in RCMT five years ago would be worth $83,295 today (with dividends reinvested), compared to $2,036 for TBI. Over the past 12 months, RCMT leads with a +38.7% total return vs MAN's -24.5%. The 3-year compound annual growth rate (CAGR) favors RCMT at 33.1% vs TBI's -28.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +45.1% | +27.5% | -0.7% | +15.1% |
| 1-Year ReturnPast 12 months | +38.7% | +31.4% | -24.5% | -18.8% |
| 3-Year ReturnCumulative with dividends | +136.0% | -62.8% | -47.2% | -33.1% |
| 5-Year ReturnCumulative with dividends | +732.9% | -79.6% | -65.5% | -57.3% |
| 10-Year ReturnCumulative with dividends | +471.3% | -70.5% | -31.5% | -32.0% |
| CAGR (3Y)Annualised 3-year return | +33.1% | -28.1% | -19.2% | -12.6% |
Risk & Volatility
Evenly matched — RCMT and MAN each lead in 1 of 2 comparable metrics.
Risk & Volatility
MAN is the less volatile stock with a 0.89 beta — it tends to amplify market swings less than RCMT's 1.18 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RCMT currently trades 88.7% from its 52-week high vs MAN's 63.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.18x | 0.98x | 0.89x | 0.96x |
| 52-Week HighHighest price in past year | $32.50 | $7.78 | $47.34 | $14.94 |
| 52-Week LowLowest price in past year | $17.26 | $3.18 | $25.15 | $7.98 |
| % of 52W HighCurrent price vs 52-week peak | +88.7% | +72.1% | +63.0% | +66.1% |
| RSI (14)Momentum oscillator 0–100 | 50.5 | 81.5 | 53.7 | 59.6 |
| Avg Volume (50D)Average daily shares traded | 67K | 387K | 1.1M | 364K |
Analyst Outlook
Evenly matched — MAN and KELYA each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: RCMT as "Buy", TBI as "Buy", MAN as "Hold", KELYA as "Buy". Consensus price targets imply 52.0% upside for KELYA (target: $15) vs -2.0% for TBI (target: $6). For income investors, MAN offers the higher dividend yield at 4.80% vs KELYA's 3.18%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $5.50 | $37.86 | $15.00 |
| # AnalystsCovering analysts | 3 | 10 | 29 | 5 |
| Dividend YieldAnnual dividend ÷ price | — | — | +4.8% | +3.2% |
| Dividend StreakConsecutive years of raises | 1 | 0 | 0 | 5 |
| Dividend / ShareAnnual DPS | — | — | $1.43 | $0.31 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.6% | +0.6% | +2.8% | +3.5% |
RCMT leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MAN leads in 1 (Valuation Metrics). 2 tied.
RCMT vs TBI vs MAN vs KELYA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is RCMT or TBI or MAN or KELYA a better buy right now?
For growth investors, RCM Technologies, Inc.
(RCMT) is the stronger pick with 14. 7% revenue growth year-over-year, versus -1. 9% for Kelly Services, Inc. (KELYA). RCM Technologies, Inc. (RCMT) offers the better valuation at 13. 4x trailing P/E (12. 4x forward), making it the more compelling value choice. Analysts rate RCM Technologies, Inc. (RCMT) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RCMT or TBI or MAN or KELYA?
On forward P/E, ManpowerGroup Inc.
is actually cheaper at 8. 1x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — RCMT or TBI or MAN or KELYA?
Over the past 5 years, RCM Technologies, Inc.
(RCMT) delivered a total return of +732. 9%, compared to -79. 6% for TrueBlue, Inc. (TBI). Over 10 years, the gap is even starker: RCMT returned +471. 3% versus TBI's -70. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RCMT or TBI or MAN or KELYA?
By beta (market sensitivity over 5 years), ManpowerGroup Inc.
(MAN) is the lower-risk stock at 0. 89β versus RCM Technologies, Inc. 's 1. 18β — meaning RCMT is approximately 33% more volatile than MAN relative to the S&P 500. On balance sheet safety, Kelly Services, Inc. (KELYA) carries a lower debt/equity ratio of 16% versus 116% for ManpowerGroup Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — RCMT or TBI or MAN or KELYA?
By revenue growth (latest reported year), RCM Technologies, Inc.
(RCMT) is pulling ahead at 14. 7% versus -1. 9% for Kelly Services, Inc. (KELYA). On earnings-per-share growth, the picture is similar: TrueBlue, Inc. grew EPS 61. 4% year-over-year, compared to -427. 4% for Kelly Services, Inc.. Over a 3-year CAGR, RCMT leads at 3. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RCMT or TBI or MAN or KELYA?
RCM Technologies, Inc.
(RCMT) is the more profitable company, earning 5. 1% net margin versus -6. 0% for Kelly Services, Inc. — meaning it keeps 5. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RCMT leads at 7. 9% versus -1. 7% for TBI. At the gross margin level — before operating expenses — RCMT leads at 26. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RCMT or TBI or MAN or KELYA more undervalued right now?
On forward earnings alone, ManpowerGroup Inc.
(MAN) trades at 8. 1x forward P/E versus 12. 4x for RCM Technologies, Inc. — 4. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KELYA: 52. 0% to $15. 00.
08Which pays a better dividend — RCMT or TBI or MAN or KELYA?
In this comparison, MAN (4.
8% yield), KELYA (3. 2% yield) pay a dividend. RCMT, TBI do not pay a meaningful dividend and should not be held primarily for income.
09Is RCMT or TBI or MAN or KELYA better for a retirement portfolio?
For long-horizon retirement investors, ManpowerGroup Inc.
(MAN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 89), 4. 8% yield). Both have compounded well over 10 years (MAN: -31. 5%, TBI: -70. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RCMT and TBI and MAN and KELYA?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: RCMT is a small-cap deep-value stock; TBI is a small-cap quality compounder stock; MAN is a small-cap income-oriented stock; KELYA is a small-cap income-oriented stock. MAN, KELYA pay a dividend while RCMT, TBI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.